- Home
- TSLX vs SLNO Comparison
TSLX vs SLNO Comparison
Compare TSLX & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSLX
- SLNO
- Stock Information
- Founded
- TSLX 2010
- SLNO 1999
- Country
- TSLX United States
- SLNO United States
- Employees
- TSLX N/A
- SLNO N/A
- Industry
- TSLX Investment Managers
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TSLX Finance
- SLNO Health Care
- Exchange
- TSLX Nasdaq
- SLNO Nasdaq
- Market Cap
- TSLX 2.1B
- SLNO 2.3B
- IPO Year
- TSLX 2014
- SLNO 2014
- Fundamental
- Price
- TSLX $22.39
- SLNO $72.63
- Analyst Decision
- TSLX Strong Buy
- SLNO Strong Buy
- Analyst Count
- TSLX 6
- SLNO 8
- Target Price
- TSLX $23.17
- SLNO $92.00
- AVG Volume (30 Days)
- TSLX 435.5K
- SLNO 1.8M
- Earning Date
- TSLX 04-30-2025
- SLNO 05-08-2025
- Dividend Yield
- TSLX 9.31%
- SLNO N/A
- EPS Growth
- TSLX N/A
- SLNO N/A
- EPS
- TSLX 2.03
- SLNO N/A
- Revenue
- TSLX $482,526,000.00
- SLNO N/A
- Revenue This Year
- TSLX N/A
- SLNO N/A
- Revenue Next Year
- TSLX $1.15
- SLNO N/A
- P/E Ratio
- TSLX $11.02
- SLNO N/A
- Revenue Growth
- TSLX 10.14
- SLNO N/A
- 52 Week Low
- TSLX $19.50
- SLNO $36.61
- 52 Week High
- TSLX $23.67
- SLNO $73.97
- Technical
- Relative Strength Index (RSI)
- TSLX 49.28
- SLNO 84.73
- Support Level
- TSLX $22.09
- SLNO $48.29
- Resistance Level
- TSLX $22.74
- SLNO $73.97
- Average True Range (ATR)
- TSLX 0.31
- SLNO 3.17
- MACD
- TSLX 0.01
- SLNO 2.78
- Stochastic Oscillator
- TSLX 71.20
- SLNO 95.19
About TSLX Sixth Street Specialty Lending Inc.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.